Regenerative Medicines Projects optimisim for Healthcare professionals

We are familiar with organ transplants, especially heart, liver and kidneys. In the event of failure of these vital organs, replacement remains the last refuge. Availability of perfectly functioning organs at the right time cannot be guaranteed due to limited number of donors and the shelf life of the organs. Moreover, organ transplant in itself is a complex operation, which can lead to immune rejections. Transplants are expensive and time consuming too.

To overcome the numerous hassles associated with transplants, researchers have come up with Regenerative Medicines. These life savers can regenerate a worn out organ by technologies like stem cell therapy, which is one of the most promising breakthroughs in modern medical science. Regenerative medicines heal the wounded or diseased organs by cellular and tissue regeneration. As per latest research conducted by Allied Market Research, the regenerative medicine market would reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). 

Following are the details for a better insight into regenerative medicines.
Major Drivers:

• Wide range of applicability
• Minimizing the need for transplants

Restraints:

• Stringent regulations
• High cost of treatment

Applications of Regenerative Medicines:

• Dermatology
• Neurodegenerative diseases
• Cardiovascular
• Orthopedic
• Central nervous system (CNS)
• Dental
• Others
  • Autoimmune disorders
  • Muscle regeneration
  • Ocular diseases

Cardiovascular applications are commercialized and the largest revenue generating segment. Extensive research in CNS makes it the fastest growing application segment at a CAGR of 30.8% during 2014-2020.

Technology-wise market segments are as follows:

• Small molecules & Biologics: Largest contributor due to their efficiency in penetrating internal membranes of the internal organs, projected to grow at a CAGR of 18.9% during the forecast period (2013-2020).
• Gene therapy: Due to their ability in minimizing immune rejection, gene therapies are expected to be the fastest emerging technology, growing at a CAGR of 28.6% during 2014-2020
• Cell therapy 

Geographies:
Due to their novel method of healing, regenerative medicines are rapidly gaining popularity in global markets. Regionally, markets are segmented into North America, Europe, Asia-Pacific and LAMEA, with North America being the largest, owing to substantial investment in regenerative products. Increasing focus on R&D in Japan & South Korea makes Asia-Pacific the fastest growing region at a CAGR of 30.9% during 2014-2020.

Major Producers:

• Shire Pharmaceuticals
• Advanced Cell Technology
• Genzyme  Athersys, Inc.
• Kinetic Concepts, Inc.
• NuVasive
• Stem Cells, Inc.
• Cytori Therapeutics, Inc.
• Cytomedix Inc.
• Mesoblast Ltd.

The ever-evolving medical field has got a major breakthrough in the form of Regenerative Medicines. Further, research and popular adoption would make regenerative medicines affordable and easily accessible in near future.

Related Post